MOG and myeloid sarcoma: In a mouse model of MS, where myelin oligodendrocyte glycoprotein (MOG) injections are used to induce T cell–mediated autoimmune encephalomyelitis, ASK1 deficiency affords significant protection against several disease-associated phenotypes.